Fundraising Fox

Neurana Pharmaceuticals

San Diego, US · Founded 2013 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

KD
Kathleen D. ScottChief Financial Officer, Secretary and Treasurer
JC
Judy CaronChief Operating Officer
DF
David F. HaleChairman of the Board of Directors, Acting President and CEO
BD
Brian DorseyDirector
DB
Daniel BeckerDirector
AZ
Alex ZissonDirector
DK
David KabakoffDirector
JR
Joshua RichardsonDirector

Investors · 2

Sofinnova VenturesMenlo Park · $100K – $15M
H.I.G. HealthBridge PartnersreportedMiami · $5M – $40Mvia Alex Zisson · board

Reported raises · per SEC filings

Form D private placements
▶$41.9MraisedFeb 2020 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua RichardsonDirector
  • David KabakoffDirector
  • Craig ThompsonDirector, Executive Officer
  • Brian DorseyDirector
  • David F. HaleDirector
  • Randall Kaye, M.D.Executive Officer
  • Kathleen D. ScottExecutive Officer
  • Alex ZissonDirector
Offering amount
$64.9M
Amount sold
$41.9M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedMay 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathleen D. ScottExecutive Officer
  • Judy CaronExecutive Officer
  • David F. HaleDirector, Executive Officer
  • Brian DorseyDirector
  • Daniel BeckerDirector
  • Alex ZissonDirector
  • David KabakoffDirector
  • Joshua RichardsonDirector
Offering amount
$3.8M
Amount sold
$3.8M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.